Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · Real-Time Price · USD
4.190
-0.440 (-9.50%)
Jun 20, 2025, 1:06 PM - Market open

Y-mAbs Therapeutics Market Cap

Y-mAbs Therapeutics has a market cap or net worth of $189.79 million as of June 20, 2025. Its market cap has decreased by -64.17% in one year.

Market Cap
189.79M
Enterprise Value
130.54M
1-Year Change
-64.17%
Ranking
Category
Stock Price
$4.19

Market Cap Chart

Since September 21, 2018, Y-mAbs Therapeutics's market cap has decreased from $796.74M to $189.79M, a decrease of -76.18%. That is a compound annual growth rate of -19.16%.

History

DateMarket Cap% Change
Jun 18, 2025209.72M-40.20%
Dec 31, 2024350.70M17.88%
Dec 29, 2023297.50M39.61%
Dec 30, 2022213.10M-69.88%
Dec 31, 2021707.47M-64.73%
Dec 31, 20202.01B61.56%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 684.60B
Johnson & Johnson 359.49B
Novo Nordisk 333.14B
AbbVie 325.71B
UnitedHealth Group 276.22B
Abbott Laboratories 230.84B
Novartis AG 227.73B
AstraZeneca 219.65B
Market Cap Rankings